News
NICE okays Roche liver cancer immunotherapy, Sanofi’s rare d...
Previously-untreated patients with hepatocellular carcinoma (HCC), a common form of liver cancer, will have an immunotherapy-based treatment option after NICE gave the nod to NHS funding of
